MEDICAL EXECUTIVE-POST – TODAY’S NEWSLETTER BRIEFING
***
Essays, Opinions and Curated News in Health Economics, Investing, Business, Management and Financial Planning for Physician Entrepreneurs and their Savvy Advisors and Consultants
“Serving Almost One Million Doctors, Financial Advisors and Medical Management Consultants Daily“
A Partner of the Institute of Medical Business Advisors , Inc.
http://www.MedicalBusinessAdvisors.com
SPONSORED BY: Marcinko & Associates, Inc.
***
http://www.MarcinkoAssociates.com
| Daily Update Provided By Staff Reporters Since 2007. How May We Serve You? |
| © Copyright Institute of Medical Business Advisors, Inc. All rights reserved. 2024 |
REFER A COLLEAGUE: MarcinkoAdvisors@msn.com
SPONSORSHIPS AVAILABLE: https://medicalexecutivepost.com/sponsors/
ADVERTISE ON THE ME-P: https://tinyurl.com/ytb5955z
Your Referral Count -0-
The FDA just approved FluMist from AstraZeneca for self- or caregiver administration for the prevention of influenza virus subtypes A and B.
Plus, August’s revised jobs report showed the US actually created 159,000 jobs, up from 142,000 initially reported last month.
People in CA will have explicit rights to their own “neural data”—covering anything a person thinks or physically/emotionally feels—which is designed to prevent companies from gathering and selling that type of personal info
COMMENTS APPRECIATED
PLEASE SUBSCRIBE: MarcinkoAdvisors@msn.com
Thank You
***
***
***
EDUCATIONAL TEXTBOOKS: https://tinyurl.com/4zdxuuwf
***
Filed under: "Ask-an-Advisor", Experts Invited, Information Technology, Investing, Marcinko Associates, Recommended Books, Sponsors | Tagged: Art, AstraZeneca, DJIA, DOW, FDA, FluMist, jobs report, Marcinko, NASA, NASDAQ, neural data, S&P 500, Science, Technology, textbooks, TNX, travel, VIX, writing, WSJ | Leave a comment »
















